ADUS

Addus HomeCare Corporation Common Stock (ADUS)

Stock · NASDAQ · Health Care

$115.98as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

ADUS: No new company-specific news in last 7 days. There is no recent news specific to Addus HomeCare Corporation in the provided data. The only article listed concerns a different company, Hims & Hers, and is not relevant to ADUS. Therefore, no company-specific developments can be summarized for this period.

Active signals

Support level
$114.48
Industry
Medical/Nursing Services

What ADUS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike30+2.5%70%
Bollinger Band Breakout23+0.2%52%
Bollinger Band Breakdown21+3.1%76%
200-Day Moving Average TouchActive now19-0.2%47%
Any 20-session window (baseline)+1.2%56%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About ADUS

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This se…

Sector
Health Care
Industry
Medical/Nursing Services
Employees
5,982
Website
addus.com/

Fundamentals

1-day range
$116.29$117.48
Market cap
$2.22B
P/E (trailing)
20.70
P/E (forward)
15.53
EPS (trailing)
$5.71
Dividend yield
—
Beta
0.76
Avg. volume
211.5K
52-week range
$87.95$124.44
Next earnings: November 3, 2026 · EPS estimate $1.79confirmed

How Addus HomeCare Corporation Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.42BNet Income$95.91M (7%)Cost of Revenue$960.66M (68%)SG&A$306.85M (22%)Tax$31.54M (2%)Other$27.58M (2%)ADUS

Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub

Gross Profit$461.87M(32%)
Operating Income$138.62M(10%)

Forecasts

13 analyst ratings

Buy 85%
Hold 10%
Sell 5%
1-year price forecast
High
$155
+33.6%
Median
$137
+18.1%
Low
$96
-17.2%

Addus HomeCare Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • ADUS
    Addus HomeCare Corporation Common Stock
    $115.98
    ▼ 0.44%
    Market cap $2.22BP/E 20.70
    $87.95$124.44
  • WGS
    GeneDx Holdings Corp. Class A Common Stock
    $63.61
    ▼ 9.41%
    Market cap $2.08BP/E —
    $32.21$170.87
  • AVAH
    Aveanna Healthcare Holdings Inc. Common Stock
    $12.34
    ▼ 2.37%
    Market cap $2.03BP/E 10.04
    $5.93$14.71
  • PRVA
    Privia Health Group Inc. Common Stock
    $22.52
    ▼ 0.44%
    Market cap $2.77BP/E 102.74
    $18.92$28.82
  • INNV
    InnovAge Holding Corp. Common Stock
    $8.85
    ▼ 1.45%
    Market cap $1.49BP/E —
    $3.94$12.64
  • PNTG
    The Pennant Group Inc. Common Stock
    $41.87
    ▼ 0.95%
    Market cap $1.36BP/E 46.02
    $22.26$42.74
  • TDOC
    Teladoc Health Inc. Common Stock
    $5.67
    ▼ 5.03%
    Market cap $1.21BP/E —
    $4.4$9.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
10.1K
Disposed
966

Institutional Ownership

March 31, 2026

Total shares held
18.69M
Total value held
$1.71B
Institutional holders
291
Top holders this quarter
  • Unknown3.09M
  • Unknown1.54M
  • Unknown867.8K
  • Unknown784.4K
  • Unknown744.1K
  • Unknown729.2K
  • Unknown721.2K
  • Unknown481.5K
  • Unknown448.9K
  • Unknown434.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.